![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EG Schuetz, WT Beck and JD Schuetz
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Xenobiotics frequently induce proteins involved in their detoxification. Because many drugs that are metabolized by human cytochromes P450 (CYP) 3A4 and 3A5 are also transported by the drug efflux pump P-glycoprotein, we determined whether expression of these proteins was altered by a variety of drugs in a cell line derived from a human colon adenocarcinoma, LS180/WT, and its adriamycin-resistant subline, LS180/AD50. P-glycoprotein and CYP3A4 were constitutively expressed in both LS180/AD50 and LS180/WT cells, and both proteins were up-regulated after treatment with many drugs, including rifampicin, phenobarbital, clotrimazole, reserpine, and isosafrole. However, there were some exceptions because P-glycoprotein was up-regulated by midazolam and nifedipine, whereas CYP3A4 was not. CYP3A5, which is also constitutively expressed in these cells, remained unchanged with most drug treatments but was up-regulated by reserpine and clotrimazole. The apparent coordinated coexpression of the CYP3A gene family and P- glycoprotein in the LS180 cells suggests that for common orally administered drugs, P-glycoprotein may play an important role in net drug absorption and drug/drug interactions of shared CYP3A4/P- glycoprotein substrates.
This article has been cited by other articles:
|
|
 |
|
  M. Shou, M. Hayashi, Y. Pan, Y. Xu, K. Morrissey, L. Xu, and G. L. Skiles Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction Drug Metab. Dispos., November 1, 2008; 36(11): 2355 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. H. Yeung, T. Sueyoshi, M. Negishi, and T. K. H. Chang Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor Drug Metab. Dispos., November 1, 2008; 36(11): 2270 - 2276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang and L.-Y. Lim Effects of Spice Constituents on P-Glycoprotein-Mediated Transport and CYP3A4-Mediated Metabolism in Vitro Drug Metab. Dispos., July 1, 2008; 36(7): 1283 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lam, N. Partovi, L. S. Ting, and M. H. Ensom Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction? Ann. Pharmacother., July 1, 2008; 42(7): 1037 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harmsen, A. S. Koster, J. H. Beijnen, J. H. M. Schellens, and I. Meijerman Comparison of Two Immortalized Human Cell Lines to Study Nuclear Receptor-Mediated CYP3A4 Induction Drug Metab. Dispos., June 1, 2008; 36(6): 1166 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsushima, K. Maeda, N. Ishiguro, T. Igarashi, and Y. Sugiyama Investigation of the Inhibitory Effects of Various Drugs on the Hepatic Uptake of Fexofenadine in Humans Drug Metab. Dispos., April 1, 2008; 36(4): 663 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Johnson, A. Owen, N. Plant, P. G. Bray, and S. A. Ward Drug-Regulated Expression of Plasmodium falciparum P-Glycoprotein Homologue 1: a Putative Role for Nuclear Receptors Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. van de Kerkhof, I. A. M. de Graaf, A.-L. B. Ungell, and G. M. M. Groothuis Induction of Metabolism and Transport in Human Intestine: Validation of Precision-Cut Slices as a Tool to Study Induction of Drug Metabolism in Human Intestine in Vitro Drug Metab. Dispos., March 1, 2008; 36(3): 604 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-A. Kim, P.-W. Park, K.-H. Liu, K.-B. Kim, H.-J. Lee, J.-G. Shin, and J.-Y. Park Effect of Rifampin, an Inducer of CYP3A and P-glycoprotein, on the Pharmacokinetics of Risperidone J. Clin. Pharmacol., January 1, 2008; 48(1): 66 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein) Oncologist, August 1, 2007; 12(8): 927 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Eap, M. Bochud, R. C. Elston, P. Bovet, M. P. Maillard, J. Nussberger, L. Schild, C. Shamlaye, and M. Burnier CYP3A5 and ABCB1 Genes Influence Blood Pressure and Response to Treatment, and Their Effect Is Modified by Salt Hypertension, May 1, 2007; 49(5): 1007 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Selbo, A. Weyergang, A. Bonsted, S. G. Bown, and K. Berg Photochemical Internalization of Therapeutic Macromolecular Agents: A Novel Strategy to Kill Multidrug-Resistant Cancer Cells J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 604 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Ghanem, P. C. Gomez, M. C. Arana, M. Perassolo, G. D. Carpini, M. G. Luquita, L. M. Veggi, V. A. Catania, L. A. Bengochea, and A. D. Mottino Induction of Rat Intestinal P-glycoprotein by Spironolactone and Its Effect on Absorption of Orally Administered Digoxin J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1146 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lazarowski, H. J. Garcia Rivello, G. L. Vera Janavel, L. A. Cuniberti, P. M. Cabeza Meckert, G. G. Yannarelli, A. Mele, A. J. Crottogini, and R. P. Laguens Cardiomyocytes of Chronically Ischemic Pig Hearts Express the MDR-1 Gene-encoded P-glycoprotein J. Histochem. Cytochem., July 1, 2005; 53(7): 845 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Perloff, S. X. Duan, P. R. Skolnik, D. J. Greenblatt, and L. L. von Moltke ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO Drug Metab. Dispos., June 1, 2005; 33(6): 764 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Volk and W. Loscher Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures Brain, June 1, 2005; 128(6): 1358 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Annaert and K. L. R. Brouwer ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metab. Dispos., March 1, 2005; 33(3): 388 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Ernest II, S. D. Hall, and D. R. Jones Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Annereau, G. Szakacs, C. J. Tucker, A. Arciello, C. Cardarelli, J. Collins, S. Grissom, B. R. Zeeberg, W. Reinhold, J. N. Weinstein, et al. Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistance Mol. Pharmacol., December 1, 2004; 66(6): 1397 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catalano, S. Rodilossi, M. R. Rippo, P. Caprari, and A. Procopio Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma Cells J. Biol. Chem., November 5, 2004; 279(45): 46706 - 46714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kim, J. A. Johnson, and H. Derendorf Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms J. Clin. Pharmacol., October 1, 2004; 44(10): 1083 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Matheny, R. Y. Ali, X. Yang, and G. M. Pollack EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES Drug Metab. Dispos., September 1, 2004; 32(9): 1008 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mitin, L. L. von Moltke, M. H. Court, and D. J. Greenblatt LEVOTHYROXINE UP-REGULATES P-GLYCOPROTEIN INDEPENDENT OF THE PREGNANE X RECEPTOR Drug Metab. Dispos., August 1, 2004; 32(8): 779 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Mills, K. A. Rose, N. Sadagopan, J. Sahi, and S. M. F. de Morais Induction of Drug Metabolism Enzymes and MDR1 Using a Novel Human Hepatocyte Cell Line J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 303 - 309. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-H. Wang, D. R. Jones, and S. D. Hall PREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITES Drug Metab. Dispos., February 1, 2004; 32(2): 259 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Song, M. Xie, H. Zhang, Y. Li, K. Sachdeva, and B. Yan THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES Drug Metab. Dispos., January 1, 2004; 32(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawaguchi, Y. Matsui, Y. Watanabe, and Y. Takakura Effect of Interferon-{gamma} on the Pharmacokinetics of Digoxin, a P-glycoprotein Substrate, Intravenously Injected into the Mouse J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 91 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Hebert, J. M. Park, Y.-L. Chen, S. Akhtar, and A. M. Larson Effects of St. John's Wort (Hypericum perforatum) on Tacrolimus Pharmacokinetics in Healthy Volunteers J. Clin. Pharmacol., January 1, 2004; 44(1): 89 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kishi, W. Yang, B. Boureau, S. Morand, S. Das, P. Chen, E. H. Cook, G. L. Rosner, E. Schuetz, C.-H. Pui, et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia Blood, January 1, 2004; 103(1): 67 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hamada, H. Miyano, H. Watanabe, and H. Saito Interaction of Imatinib Mesilate with Human P-Glycoprotein J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 824 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Johnson, W. N. Charman, and C. J. H. Porter APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A Drug Metab. Dispos., September 1, 2003; 31(9): 1151 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. P. D. Lemahieu, B. D. Maes, Y. Ghoos, P. Rutgeerts, K. Verbeke, and Y. Vanrenterghem Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G470 - G482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zong and G. M. Pollack Modulation of P-glycoprotein Transport Activity in the Mouse Blood-Brain Barrier by Rifampin J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 556 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Goodman and A. B. Pardee Evidence for defective retinoid transport and function in late onset Alzheimer's disease PNAS, March 4, 2003; 100(5): 2901 - 2905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawana, T. Ikuta, Y. Kobayashi, O. Gotoh, K. Takeda, and K. Kawajiri Molecular Mechanism of Nuclear Translocation of an Orphan Nuclear Receptor, SXR Mol. Pharmacol., March 1, 2003; 63(3): 524 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Veau, L. Faivre, S. Tardivel, M. Soursac, H. Banide, B. Lacour, and R. Farinotti Effect of Interleukin-2 on Intestinal P-glycoprotein Expression and Functionality in Mice J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 742 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Luo, P. V. Paranjpe, A. Guo, E. Rubin, and P. Sinko Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1 Drug Metab. Dispos., July 1, 2002; 30(7): 763 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Brady, N. J. Cherrington, D. P. Hartley, S. C. Buist, N. Li, and C. D. Klaassen Tissue Distribution and Chemical Induction of Multiple Drug Resistance Genes in Rats Drug Metab. Dispos., July 1, 2002; 30(7): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Crews, C. F. Stewart, D. Jones-Wallace, S. J. Thompson, P. J. Houghton, R. L. Heideman, M. Fouladi, D. C. Bowers, M. M. Chintagumpala, and A. Gajjar Altered Irinotecan Pharmacokinetics in Pediatric High-Grade Glioma Patients Receiving Enzyme-inducing Anticonvulsant Therapy Clin. Cancer Res., July 1, 2002; 8(7): 2202 - 2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Burk, H. Tegude, I. Koch, E. Hustert, R. Wolbold, H. Glaeser, K. Klein, M. F. Fromm, A. K. Nuessler, P. Neuhaus, et al. Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine J. Biol. Chem., June 28, 2002; 277(27): 24280 - 24288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Podvinec, M. R. Kaufmann, C. Handschin, and U. A. Meyer NUBIScan, an in Silico Approach for Prediction of Nuclear Receptor Response Elements Mol. Endocrinol., June 1, 2002; 16(6): 1269 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Audus, M. J. Soares, and J. S. Hunt Characteristics of the Fetal/Maternal Interface with Potential Usefulness in the Development of Future Immunological and Pharmacological Strategies J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Y. Li, G. L. Amidon, J. S. Kim, T. Heimbach, F. Kesisoglou, J. T. Topliss, and D. Fleisher Intestinal Metabolism Promotes Regional Differences in Apical Uptake of Indinavir: Coupled Effect of P-Glycoprotein and Cytochrome P450 3A on Indinavir Membrane Permeability in Rat J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 586 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ekins, R. B. Kim, B. F. Leake, A. H. Dantzig, E. G. Schuetz, L.-B. Lan, K. Yasuda, R. L. Shepard, M. a Winter, J. D. Schuetz, et al. Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates Mol. Pharmacol., May 1, 2002; 61(5): 974 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Loscher and H. Potschka Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Cummins, W. Jacobsen, and L. Z. Benet Unmasking the Dynamic Interplay between Intestinal P-Glycoprotein and CYP3A4 J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Asghar, J. C. Gorski, B. Haehner-Daniels, and S. D. Hall Induction of Multidrug Resistance-1 and Cytochrome P450 mRNAs in Human Mononuclear Cells by Rifampin Drug Metab. Dispos., January 1, 2002; 30(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Sisodiya, W.-R. Lin, B. N. Harding, M. V. Squier, and M. Thom Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy Brain, January 1, 2002; 125(1): 22 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Guo, S. Choudhuri, and C. D. Klaassen Induction Profile of Rat Organic Anion Transporting Polypeptide 2 (oatp2) by Prototypical Drug-Metabolizing Enzyme Inducers That Activate Gene Expression through Ligand-Activated Transcription Factor Pathways J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zembutsu, Y. Ohnishi, T. Tsunoda, Y. Furukawa, T. Katagiri, Y. Ueyama, N. Tamaoki, T. Nomura, O. Kitahara, R. Yanagawa, et al. Genome-wide cDNA Microarray Screening to Correlate Gene Expression Profiles with Sensitivity of 85 Human Cancer Xenografts to Anticancer Drugs Cancer Res., January 1, 2002; 62(2): 518 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin, H. Ishizuka, E. Kharasch, J. Schuetz, and E. Schuetz Transcriptional Control of Intestinal Cytochrome P-4503A by 1alpha ,25-Dihydroxy Vitamin D3 Mol. Pharmacol., December 1, 2001; 60(6): 1399 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schmiedlin-Ren, K. E. Thummel, J. M. Fisher, M. F. Paine, and P. B. Watkins Induction of CYP3A4 by 1alpha ,25-Dihydroxyvitamin D3 Is Human Cell Line-Specific and Is Unlikely to Involve Pregnane X Receptor Drug Metab. Dispos., November 1, 2001; 29(11): 1446 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Schuetz, S. Strom, K. Yasuda, V. Lecureur, M. Assem, C. Brimer, J. Lamba, R. B. Kim, V. Ramachandran, B. J. Komoroski, et al. Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450 J. Biol. Chem., October 12, 2001; 276(42): 39411 - 39418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shu, C. L. Bello, L. M. Mangravite, B. Feng, and K. M. Giacomini Functional Characteristics and Steroid Hormone-Mediated Regulation of an Organic Cation Transporter in Madin-Darby Canine Kidney Cells J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ekins, M. J. de Groot, and J. P. Jones Pharmacophore and Three-Dimensional Quantitative Structure Activity Relationship Methods for Modeling Cytochrome P450 Active Sites Drug Metab. Dispos., July 1, 2001; 29(7): 936 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Huang, S. A. Wring, J. L. Woolley, K. R. Brouwer, C. Serabjit-Singh, and J. W. Polli Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors Drug Metab. Dispos., April 13, 2001; 29(5): 754 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
R. Yumoto, T. Murakami, M. Sanemasa, R. Nasu, J. Nagai, and M. Takano Pharmacokinetic Interaction of Cytochrome P450 3A-Related Compounds with Rhodamine 123, a P-Glycoprotein Substrate, in Rats Pretreated with Dexamethasone Drug Metab. Dispos., February 1, 2001; 29(2): 145 - 151. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Renders, I. Mayer-Kadner, C. Koch, S. Scharffe, K. Burkhardt, R. Veelken, Roland. E. Schmieder, and I. A. Hauser Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients Nephrol. Dial. Transplant., January 1, 2001; 16(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Pascussi, L. Drocourt, J.-M. Fabre, P. Maurel, and M.-J. Vilarem Dexamethasone Induces Pregnane X Receptor and Retinoid X Receptor-alpha Expression in Human Hepatocytes: Synergistic Increase of CYP3A4 Induction by Pregnane X Receptor Activators Mol. Pharmacol., August 1, 2000; 58(2): 361 - 372. [Abstract] [Full Text]
|
|
